Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Tables)

v3.24.1
Shareholders' Deficit (Tables)
12 Months Ended
Dec. 31, 2023
Shareholders' Deficit (Tables) [Line Items]
Schedule of Activity Related to Non-Vested Shares The following table summarizes activity related to non-vested shares:
Number of
Non-Vested
Shares
Weighted
Average
Grant Date
Fair Value
Non-vested, December 31, 2021 14,270,120 $ 0.140
Granted 3,500,000 0.014
Shares vested (800,000 ) (0.037 )
Non-vested, December 31, 2022 16,970,120 0.119
Shares vested (2,000,000 ) (0.021 )
Non-vested, December 31, 2023 14,970,120 $ 0.132
Stock Options [Member]
Shareholders' Deficit (Tables) [Line Items]
Schedule of Stock option activities Stock option activities for the years ended December 31, 2023 and 2022 are summarized as follows:
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Balance Outstanding, December 31, 2021 8,445,698 $ 0.40 4.43
-
Exercised
-
-
-
-
Balance Outstanding, December 31, 2022 8,445,698 0.40 3.43
-
Exercised
-
-
-
-
Balance Outstanding, December 31, 2023 8,445,698 $ 0.40 2.43 $
-
Exercisable, December 31, 2023 8,445,698 $ 0.40 2.43 $
-
Warrant [Member]
Shareholders' Deficit (Tables) [Line Items]
Schedule of Stock option activities Warrant activities for the years ended December 31, 2023 and 2022 are summarized as follows:
Number of
Warrants
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Balance Outstanding December 31, 2021 17,500,000 $ 0.05 4.67 $
-
Granted 33,000,000 0.025
-
-
Cancelled (16,500,000 ) (0.05 )
-
-
Balance Outstanding December 31, 2022 34,000,000 0.011 3.73
-
Granted
-
-
-
-
Balance Outstanding December 31, 2023 34,000,000 $ 0.011 2.73 $
-
Exercisable, December 31, 2023 34,000,000 $ 0.011 2.73 $
-